The Arthritis Drug Market report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.
Arthritis Drug Market: Drivers and Challenges
Growing burden of incidence of osteoarthritis, psoriatic arthritis and rheumatoid arthritis patients are major factors driving the growth of global arthritis drugs market. According to CDC estimation from 2010-2012, about 52.5 million US adults had some form of arthritis conditions among them persons with age 65 or older reported higher prevalence of arthritis conditions than the other ages due to “wear and tear” on the joints. However, due to lack of proper medication to cure arthritis and higher cost of the medications are hindering the growth of this market over the forecast period.
Arthritis Drug Market: Key Players
Some of the major players in global Arthritis Drugs market are Novartis AG, Eli Lilly, Celltrion, F. Hoffmann-La Roche Ltd, Pfizer Inc and Johnson & Johnson Services Inc., and GSK
A Sample of this Report is Available Upon Request @http://www.persistencemarketresearch.com/samples/14296
Arthritis Drug Market:Regional Overview
On the basis of regional presence, global arthritis drugs market is segmented into five key regions viz. North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. North America is expected to increase over the forecast period due to increase in number of arthritis patients, rise in awareness among people and improved healthcare infrastructure in the region. Asia Pacific market is projected to grow with significant CAGR over the forecast period due to large pool of population, increase in R & D activities of biosimilars, growing awareness is contributing the growth of this market.
To View TOC of this Report is Available Upon Request @ http://www.persistencemarketresearch.com/toc/14296